BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24918664)

  • 21. Lymph node trafficking of regulatory T cells is prerequisite for immune suppression.
    Huang MT; Lin BR; Liu WL; Lu CW; Chiang BL
    J Leukoc Biol; 2016 Apr; 99(4):561-8. PubMed ID: 26543091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The tumor-draining lymph node as an immune-privileged site.
    Munn DH; Mellor AL
    Immunol Rev; 2006 Oct; 213():146-58. PubMed ID: 16972902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Central role of tumor-associated CD8+ T effector/memory cells in restoring systemic antitumor immunity.
    Kilinc MO; Gu T; Harden JL; Virtuoso LP; Egilmez NK
    J Immunol; 2009 Apr; 182(7):4217-25. PubMed ID: 19299720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory B cells in anti-tumor immunity.
    Zhang Y; Gallastegui N; Rosenblatt JD
    Int Immunol; 2015 Oct; 27(10):521-30. PubMed ID: 25999597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of anergic or regulatory tumor-specific CD4
    Alonso R; Flament H; Lemoine S; Sedlik C; Bottasso E; Péguillet I; Prémel V; Denizeau J; Salou M; Darbois A; Núñez NG; Salomon B; Gross D; Piaggio E; Lantz O
    Nat Commun; 2018 May; 9(1):2113. PubMed ID: 29844317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical inhibition of T cell costimulatory pathways in draining lymph nodes may suppress allograft rejection.
    Li Y; Han Y; Xia W; Guo SZ
    Med Hypotheses; 2011 Mar; 76(3):441-4. PubMed ID: 21134721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics and in vivo homing of long-term T-cell lines and clones derived from tumor-draining lymph nodes.
    Matsumura T; Sussman JJ; Krinock RA; Chang AE; Shu S
    Cancer Res; 1994 May; 54(10):2744-50. PubMed ID: 8168105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF.
    Aruga E; Aruga A; Arca MJ; Lee WM; Yang NS; Smith JW; Chang AE
    Cancer Gene Ther; 1997; 4(3):157-66. PubMed ID: 9171934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral ingestion of Lentinula edodes mycelia extract can restore the antitumor T cell response of mice inoculated with colon-26 cells into the subserosal space of the cecum.
    Tanaka K; Matsui Y; Ishikawa S; Kawanishi T; Harada M
    Oncol Rep; 2012 Feb; 27(2):325-32. PubMed ID: 22086364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulatory dendritic cell expression of MHCII and IL-10 are jointly requisite for induction of tolerance in a murine model of OVA-asthma.
    Huang H; Dawicki W; Lu M; Nayyar A; Zhang X; Gordon JR
    Allergy; 2013 Sep; 68(9):1126-35. PubMed ID: 23910017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alteration of CD4 T cell subsets in metastatic lymph nodes of human gastric cancer.
    Okita Y; Ohira M; Tanaka H; Tokumoto M; Go Y; Sakurai K; Toyokawa T; Kubo N; Muguruma K; Sawada T; Maeda K; Hirakawa K
    Oncol Rep; 2015 Aug; 34(2):639-47. PubMed ID: 26081040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymph nodes and human tumors (review).
    Lores B; García-Estevez JM; Arias C
    Int J Mol Med; 1998 Apr; 1(4):729-33. PubMed ID: 9852289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-reactivity of anti-CD3/IL-2 activated effector cells derived from lymph nodes draining heterologous clones of a murine tumor.
    Matsumura T; Krinock RA; Chang AE; Shu S
    Cancer Res; 1993 Sep; 53(18):4315-21. PubMed ID: 8364926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Precise Spatiotemporal Interruption of Regulatory T-cell-Mediated CD8
    Zhou X; Zhao S; He Y; Geng S; Shi Y; Wang B
    Cancer Res; 2019 Feb; 79(3):585-597. PubMed ID: 30254146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional oral tolerance in transgenic 2C mice.
    Margenthaler JA; Flye MW
    Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+CD25+Foxp3+ regulatory T cells are dispensable for controlling CD8+ T cell-mediated lung inflammation.
    Tosiek MJ; Gruber AD; Bader SR; Mauel S; Hoymann HG; Prettin S; Tschernig T; Buer J; Gereke M; Bruder D
    J Immunol; 2011 Jun; 186(11):6106-18. PubMed ID: 21518973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymph node stromal cells strongly influence immune response suppression.
    Buettner M; Pabst R; Bode U
    Eur J Immunol; 2011 Mar; 41(3):624-33. PubMed ID: 21246540
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells.
    Dye ES
    J Immunol; 1986 Feb; 136(4):1510-5. PubMed ID: 3080526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotype analyses and cellular mechanisms of the pre-effector T-lymphocyte response to a progressive syngeneic murine sarcoma.
    Sakai K; Chang AE; Shu SY
    Cancer Res; 1990 Jul; 50(14):4371-6. PubMed ID: 2114215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
    Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
    Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.